Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 8UNKNOWN 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 6Breast 5Thoracic 4Sarcoma 3Gynecologic 2Genitourinary 1Dermatologic 1CNS 1

Conditions

Sarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Familial ependymoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Radiotherapy 58Temozolomide 37Vincristine 33Cyclophosphamide 31Etoposide 25Carboplatin 25Filgrastim 23Cisplatin 22Granulocyte Colony-Stimulating Factor 18Lomustine 14Doxorubicin 13Chemotherapy, Adjuvant 13Peripheral Blood Stem Cell Transplantation 12Magnetic Resonance Spectroscopy 12Topotecan 11Radiation 11Isotretinoin 11Platinum 10sargramostim 9Specimen Handling 9Radiotherapy, Conformal 9Irinotecan 9Carmustine 91,2-diaminocyclohexaneplatinum II citrate 9etoposide phosphate 8Thiotepa 8Radiotherapy, Intensity-Modulated 8Radiosurgery 8Melphalan 8Immunohistochemistry 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Vinorelbine × CNS × Clear all
NCT00003234 2014-07-28

Vinorelbine in Treating Children With Recurrent or Refractory Cancers

Children's Oncology Group

Phase 2 Completed
50 enrolled
CNSSarcoma

Familial ependymoma, Astrocytoma, Neuroblastoma, Sarcoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡